FP447C3A AND C5A RECEPTOR ANTAGONISTS AMELIORATE ENDOTHELIAL-MYOFIBROBLAST TRANSITION VIA WNT/β-CATENIN SIGNALING PATHWAY IN DIABETIC KIDNEY DISEASE
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.